Innovating
in skin care
Research focused in developing dermatological medicines to fulfill patient’s needs and promote responsible health self-help [+]
Ojer Pharma, contributing to the R&D enhancement of Navarra
Monday, June 16th, 2008
The scientific manager of the laboratories explains in a newspaper interview Ojer Pharma’s contribution to the development of the dermatological R&D of the region […]
Digna Biotech biotechnological company and Isdin Laboratory begin Phase II of a product for scleroderma
Friday, October 19th, 2007
Digna Biotech and Isdin begin Phase II clinical trials on p-144 peptide for scleroderma […]
